newsfilter
← Latest News
Business Wire·

Quince Therapeutics to Participate at Investor Events in December 2025

Quince Therapeutics, Inc. (NASDAQ:QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, today announced that senior management will